On October 3, 2023, Scinai Immunotherapeutics Ltd. closed the transaction. The transaction included participation from a single investor
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 USD | -3.30% | +0.09% | -26.10% |
1st Jan change | Capi. | |
---|---|---|
-26.10% | 1.91M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- SCNI Stock
- News Scinai Immunotherapeutics Ltd.
- Scinai Immunotherapeutics Ltd. announced that it has received $1.329254 million in funding